Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02908061 · ClinicalTrials.gov registry record · Phase 3

A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia

A Phase 3 study of Radical Cystectomy, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
Phase 3
Development phase
178
Enrollment target
7
Study locations

NCT02908061 is a Phase 3 study of Radical Cystectomy that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 178 participants. The trial reports 7 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02908061, a Phase 3 study of Radical Cystectomy, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
178 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to compare any good and bad effects of using Ultrapro mesh along with the usual bladder removal surgery, versus having the usual bladder removal surgery without the use of the mesh.

Conditions Studied

Interventions

  • PROCEDURE Surgery Radical Cystectomy
  • PROCEDURE Ultrapro mesh

Study Locations (7)

New York

  • Memorial Sloan Kettering Commack (Consent and follow-up only) - Commack
  • Memorial Sloan Kettering Westchester (Consent and follow-up only) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Consent only and Follow Up) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Consent and follow-up only) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent and follow-up only) - Montvale

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2016-08
Est. Completion 2026-08
Phase Phase 3

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT02908061

The ClinicalTrials.gov registry entry for NCT02908061 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Radical Cystectomy appearing as the primary indexed condition, and to 2 interventions - of which Surgery Radical Cystectomy is the first listed.

NCT02908061 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT02908061 about?

NCT02908061 is a clinical study titled "A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia". The purpose of this study is to compare any good and bad effects of using Ultrapro mesh along with the usual bladder removal surgery, versus having the usual bladder removal surgery without the use of the mesh.

What is the current status of trial NCT02908061?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 178 participants. The study started on 2016-08. Estimated completion is 2026-08.

What conditions does trial NCT02908061 study?

This clinical trial studies the following conditions: Radical Cystectomy.

What interventions are being tested in trial NCT02908061?

The interventions under investigation include: Surgery Radical Cystectomy (PROCEDURE), Ultrapro mesh (PROCEDURE).

Who is sponsoring clinical trial NCT02908061?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02908061 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Radical Cystectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.